KYTX
insider transactionsKyverna Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
20.6K sh
Own New
-
Grant·A
Director
$0
5.1K sh
Own +31%
-
Other·F
Christi Shaw KEY
Executive Chairperson
$36.0K
4.2K sh · $8.59
Own -6%
-
Grant·A
Director
$0
20.6K sh
Own New
-
Grant·A
Director
$0
5.1K sh
Own +31%
-
Grant·A
Chief Financial Officer
$0
325.0K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
300.0K sh
Own New
-
Grant·A
Marc Grasso KEY
Chief Financial Officer
$0
65.0K sh
Own New
-
Grant·A
Marc Grasso KEY
Chief Financial Officer
$0
10.0K sh
Own New
-
Grant·A
Exhibit 24 - Power of Attorne…
$0
105.0K sh
Own New
-
Grant·A
Exhibit 24 - Power of Attorne…
$0
18.0K sh
Own New
-
Grant·A
Chief Executive Officer
$0
350.0K sh
Own New
-
Grant·A
Chief Executive Officer
$0
58.0K sh
Own New
-
Grant·A
Director
$0
42.9K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
42.9K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Chief Technology Officer
$0
300.0K sh
Own New
-
Grant·A
Christi Shaw KEY
Executive Chairperson
$0
185.0K sh
Own New
-
Grant·A
Christi Shaw KEY
Executive Chairperson
$0
24.3K sh
Own +52%
-
Grant·A
Christi Shaw KEY
Executive Chairperson
$0
30.0K sh
Own +180%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Beth C Seidenberg | Grant A | 20.6K | $0 |
| May 27, 2026 | Beth C Seidenberg | Grant A | 5.1K | $0 |
| May 27, 2026 | Christi Shaw KEY | Other F | 4.2K | $36.0K |
| May 27, 2026 | Mert Aktar | Grant A | 20.6K | $0 |
| May 27, 2026 | Mert Aktar | Grant A | 5.1K | $0 |
| May 18, 2026 | Gregory S. Martini KEY | Grant A | 325.0K | $0 |
| May 4, 2026 | Nadia Dac | Grant A | 300.0K | $0 |
| Mar 13, 2026 | Marc Grasso KEY | Grant A | 65.0K | $0 |
| Mar 13, 2026 | Marc Grasso KEY | Grant A | 10.0K | $0 |
| Mar 13, 2026 | Naji Gehchan | Grant A | 105.0K | $0 |
| Mar 13, 2026 | Naji Gehchan | Grant A | 18.0K | $0 |
| Mar 13, 2026 | Warner Weston Biddle KEY | Grant A | 350.0K | $0 |
| Mar 13, 2026 | Warner Weston Biddle KEY | Grant A | 58.0K | $0 |
| Feb 24, 2026 | Andrew Craig Miller | Grant A | 42.9K | $0 |
| Feb 24, 2026 | Andrew Craig Miller | Grant A | 11.0K | $0 |
| Feb 24, 2026 | Sravan Kumar Emany | Grant A | 42.9K | $0 |
| Feb 24, 2026 | Sravan Kumar Emany | Grant A | 11.0K | $0 |
| Feb 9, 2026 | Mayobanex Pujols | Grant A | 300.0K | $0 |
| Jan 12, 2026 | Christi Shaw KEY | Grant A | 185.0K | $0 |
| Jan 12, 2026 | Christi Shaw KEY | Grant A | 24.3K | $0 |
| Jan 12, 2026 | Christi Shaw KEY | Grant A | 30.0K | $0 |
About KYTX insider trading
This page tracks insider transactions for Kyverna Therapeutics, Inc. (KYTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.